Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway.
Recursion Pharmaceuticals jumped by 16.44 percent on Wednesday to close at $6.09 apiece as investors repositioned portfolios ahead of expected updates from an upcoming AI conference in Dubai.
Zacks Investment Research on MSN
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, which registered a loss of 0.38% for the day. Meanwhile, the Dow experienced ...
Deep Learning with Yacine on MSN
Uninformed Search in AI Using BFS – Java Implementation Tutorial
Learn how to implement an uninformed search algorithm using Breadth-First Search (BFS) in Java! This tutorial walks you through the concepts, code, and practical examples for AI problem solving. #Arti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback